The SWOG S1602 trial ( NCT03091660) evaluated the noninferiority of the Tokyo versus TICE BCG strains, as well as testing the superiority of T cell priming with intradermal BC before intravesical ...
Whether BCG strains other than BCG TICE are safe and effective for treating high-grade NMIBC warrants rigorous testing.
Expert Rev Vaccines. 2013;12(12):1431-1448. There are two trends in TB vaccine development that warrant mentioning. First, there is a new interest in BCG and novel TB vaccines for prevention of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results